Human Endogenous Retrovirus K Gag Coassembles with HIV-1 Gag and Reduces the Release Efficiency and Infectivity of HIV-1
Overview
Affiliations
Human endogenous retroviruses (HERVs), which are remnants of ancestral retroviruses integrated into the human genome, are defective in viral replication. Because activation of HERV-K and coexpression of this virus with HIV-1 have been observed during HIV-1 infection, it is conceivable that HERV-K could affect HIV-1 replication, either by competition or by cooperation, in cells expressing both viruses. In this study, we found that the release efficiency of HIV-1 Gag was 3-fold reduced upon overexpression of HERV-K(CON) Gag. In addition, we observed that in cells expressing Gag proteins of both viruses, HERV-K(CON) Gag colocalized with HIV-1 Gag at the plasma membrane. Furthermore, HERV-K(CON) Gag was found to coassemble with HIV-1 Gag, as demonstrated by (i) processing of HERV-K(CON) Gag by HIV-1 protease in virions, (ii) coimmunoprecipitation of virion-associated HERV-K(CON) Gag with HIV-1 Gag, and (iii) rescue of a late-domain-defective HERV-K(CON) Gag by wild-type (WT) HIV-1 Gag. Myristylation-deficient HERV-K(CON) Gag localized to nuclei, suggesting cryptic nuclear trafficking of HERV-K Gag. Notably, unlike WT HERV-K(CON) Gag, HIV-1 Gag failed to rescue myristylation-deficient HERV-K(CON) Gag to the plasma membrane. Efficient colocalization and coassembly of HIV-1 Gag and HERV-K Gag also required nucleocapsid (NC). These results provide evidence that HIV-1 Gag heteromultimerizes with HERV-K Gag at the plasma membrane, presumably through NC-RNA interaction. Intriguingly, HERV-K Gag overexpression reduced not only HIV-1 release efficiency but also HIV-1 infectivity in a myristylation- and NC-dependent manner. Altogether, these results indicate that Gag proteins of endogenous retroviruses can coassemble with HIV-1 Gag and modulate the late phase of HIV-1 replication.
Human endogenous retroviruses and exogenous viral infections.
Bao C, Gao Q, Xiang H, Shen Y, Chen Q, Gao Q Front Cell Infect Microbiol. 2024; 14:1439292.
PMID: 39397863 PMC: 11466896. DOI: 10.3389/fcimb.2024.1439292.
Antibodies against endogenous retroviruses.
Chisca M, Larouche J, Xing Q, Kassiotis G Immunol Rev. 2024; 328(1):300-313.
PMID: 39152687 PMC: 11659944. DOI: 10.1111/imr.13378.
Hossain M, Nyame P, Monde K Biomolecules. 2024; 14(3).
PMID: 38540701 PMC: 10968565. DOI: 10.3390/biom14030280.
Maeda Y, Monde K, Terasawa H, Tanaka Y, Sawa T Int J Mol Sci. 2023; 24(22).
PMID: 38003710 PMC: 10671467. DOI: 10.3390/ijms242216520.
Wang D, Gomes M, Mo Y, Prohaska C, Zhang L, Chelvanambi S Int J Mol Sci. 2023; 24(8).
PMID: 37108634 PMC: 10138839. DOI: 10.3390/ijms24087472.